Discovery of DF-461, a Potent Squalene Synthase Inhibitor
Author:
Affiliation:
1. R&D Division, Daiichi Sankyo Co., Ltd., 1-2-58 Hiromachi, Shinagawa-ku, Tokyo 140-8710, Japan
Publisher
American Chemical Society (ACS)
Subject
Organic Chemistry,Drug Discovery,Biochemistry
Link
https://pubs.acs.org/doi/pdf/10.1021/ml400151c
Reference23 articles.
1. Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors
2. Management of Primary Hyperlipidemia
3. Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
4. Myopathy and rhabdomyolysis with lipid-lowering drugs
5. Statin-Associated Myopathy
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Inhibitors of Farnesyl Diphosphate Synthase and Squalene Synthase: Potential Source for Anti-Trypanosomatidae Drug Discovery;Drugs and Drug Candidates;2023-08-04
2. Unveiling the Therapeutic Potential of Squalene Synthase: Deciphering Its Biochemical Mechanism, Disease Implications, and Intriguing Ties to Ferroptosis;Cancers;2023-07-22
3. Effect of a new squalene synthase inhibitor on an ApoE−/− mouse model of atherosclerosis;Bioorganic & Medicinal Chemistry;2023-07
4. Identification of non-conventional small molecule degraders and stabilizers of squalene synthase;2023-06-05
5. Identification of non-conventional small molecule degraders and stabilizers of squalene synthase;Chemical Science;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3